Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/4033
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMARINGWA, John-
dc.contributor.authorFAES, Christel-
dc.contributor.authorAERTS, Marc-
dc.contributor.authorGEYS, Helena-
dc.contributor.authorTEUNS, Greet-
dc.contributor.authorVan Den Poel, B.-
dc.contributor.authorBIJNENS, Luc-
dc.date.accessioned2007-12-07T14:52:12Z-
dc.date.available2007-12-07T14:52:12Z-
dc.date.issued2007-
dc.identifier.citationJOURNAL OF BIOPHARMACEUTICAL STATISTICS, 17(3). p. 493-509-
dc.identifier.issn1054-3406-
dc.identifier.urihttp://hdl.handle.net/1942/4033-
dc.description.abstractA number of methods to formally incorporate historical control information in preclinical safety evaluation studies have been proposed in literature. However, it remains unclear when one should use historical data. Focusing on the logistic-normal model, we investigate situations where historical studies may prove to be useful. Aspects of estimation (precision and bias) and testing (power) for treatment effect are investigated under different conditions such as the number of historical control studies, the degree of homogeneity amongst them, the level of treatment effect and different control rates. The possibility to use a selected subset of historical control studies is also explored.-
dc.language.isoen-
dc.publisherTAYLOR & FRANCIS INC-
dc.subject.otherbias; dose-trend; empirical Bayes estimates; examined study; historical control studies; logistic-normal model; power; precision-
dc.titleOn the use of historical control data in pre-clinical safety studies-
dc.typeJournal Contribution-
dc.identifier.epage509-
dc.identifier.issue3-
dc.identifier.spage493-
dc.identifier.volume17-
local.format.pages17-
local.bibliographicCitation.jcatA1-
dc.description.notesUniv Hasselt, Ctr Stat, BE-3500 Diepenbeek, Belgium. Johnson & Johnson Pharmaceut Res & Dev, Beerse, Belgium.MARRINGWA, JT, Univ Hasselt, Ctr Stat, BE-3500 Diepenbeek, Belgium.john.maringwa@uhasselt.be-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.bibliographicCitation.oldjcatA1-
dc.identifier.doi10.1080/10543400701216355-
dc.identifier.isi000246725000010-
item.validationecoom 2008-
item.accessRightsClosed Access-
item.fullcitationMARINGWA, John; FAES, Christel; AERTS, Marc; GEYS, Helena; TEUNS, Greet; Van Den Poel, B. & BIJNENS, Luc (2007) On the use of historical control data in pre-clinical safety studies. In: JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 17(3). p. 493-509.-
item.fulltextNo Fulltext-
item.contributorMARINGWA, John-
item.contributorFAES, Christel-
item.contributorAERTS, Marc-
item.contributorGEYS, Helena-
item.contributorTEUNS, Greet-
item.contributorVan Den Poel, B.-
item.contributorBIJNENS, Luc-
crisitem.journal.issn1054-3406-
crisitem.journal.eissn1520-5711-
Appears in Collections:Research publications
Show simple item record

SCOPUSTM   
Citations

4
checked on Sep 3, 2020

WEB OF SCIENCETM
Citations

5
checked on Mar 13, 2024

Page view(s)

58
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.